PROCR and neoplasm: This stemmed from our previous work highlighting EPCR as a direct ligand for Vδ2‐negative γδ T cells 14, 15, which are the predominant tissue subset of these unconventional T cells, and are thought to possess potent anti‐tumour effector capabilities.